Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Prevalence and clinical features associated with bipolar disorder polypharmacy: a systematic review.

Fornaro M, De Berardis D, Koshy AS, Perna G, Valchera A, Vancampfort D, Stubbs B.

Neuropsychiatr Dis Treat. 2016 Mar 31;12:719-35. doi: 10.2147/NDT.S100846. eCollection 2016. Review.

2.

Reducing Adverse Polypharmacy in Patients With Borderline Personality Disorder: An Empirical Case Study.

Madan A, Oldham JM, Gonzalez S, Fowler JC.

Prim Care Companion CNS Disord. 2015 Jul 30;17(4). doi: 10.4088/PCC.14m01760. eCollection 2015.

3.

Drug treatment patterns in bipolar disorder: analysis of long-term self-reported data.

Bauer M, Glenn T, Alda M, Sagduyu K, Marsh W, Grof P, Munoz R, Severus E, Ritter P, Whybrow PC.

Int J Bipolar Disord. 2013 May 3;1:5. doi: 10.1186/2194-7511-1-5. eCollection 2013.

4.

European Network of Bipolar Research Expert Centre (ENBREC): a network to foster research and promote innovative care.

Henry C, Andreassen OA, Barbato A, Demotes-Mainard J, Goodwin G, Leboyer M, Vieta E, Nolen WA, Kessing LV, Scott J, Bauer M; ENBREC study group.

Int J Bipolar Disord. 2013 Apr 17;1:2. doi: 10.1186/2194-7511-1-2. eCollection 2013. Review.

5.

Medication burden in bipolar disorder: a chart review of patients at psychiatric hospital admission.

Weinstock LM, Gaudiano BA, Epstein-Lubow G, Tezanos K, Celis-Dehoyos CE, Miller IW.

Psychiatry Res. 2014 Apr 30;216(1):24-30. doi: 10.1016/j.psychres.2014.01.038. Epub 2014 Feb 1.

6.

Pregnancy outcomes following maternal exposure to second-generation antipsychotics given with other psychotropic drugs: a cohort study.

Sadowski A, Todorow M, Yazdani Brojeni P, Koren G, Nulman I.

BMJ Open. 2013 Jul 13;3(7). pii: e003062. doi: 10.1136/bmjopen-2013-003062. Print 2013.

7.

Epidemiology and treatment of mood disorders in a day hospital setting from 1996 to 2007: an Italian study.

Luca M, Prossimo G, Messina V, Luca A, Romeo S, Calandra C.

Neuropsychiatr Dis Treat. 2013;9:169-76. doi: 10.2147/NDT.S39227. Epub 2013 Feb 7.

8.

Mono- and combination drug therapies in hospitalized patients with bipolar depression. Data from the European drug surveillance program AMSP.

Haeberle A, Greil W, Russmann S, Grohmann R.

BMC Psychiatry. 2012 Sep 21;12:153. doi: 10.1186/1471-244X-12-153.

9.

Measuring severe adverse events and medication selection using a "PEER Report" for nonpsychotic patients: a retrospective chart review.

Hoffman DA, Debattista C, Valuck RJ, Iosifescu DV.

Neuropsychiatr Dis Treat. 2012;8:277-84. doi: 10.2147/NDT.S31665. Epub 2012 Jun 21.

10.

Polypharmacy or medication washout: an old tool revisited.

Hoffman DA, Schiller M, Greenblatt JM, Iosifescu DV.

Neuropsychiatr Dis Treat. 2011;7:639-48. doi: 10.2147/NDT.S24375. Epub 2011 Oct 20.

11.

The use of atypical antipsychotics in Bipolar Spectrum disorders.

Grünze H, Möller HJ.

Indian J Psychiatry. 2003 Jan;45(1):10-5.

12.

A review of bipolar disorder in adults.

Hilty DM, Leamon MH, Lim RF, Kelly RH, Hales RE.

Psychiatry (Edgmont). 2006 Sep;3(9):43-55.

13.

CRY2 is associated with rapid cycling in bipolar disorder patients.

Sjöholm LK, Backlund L, Cheteh EH, Ek IR, Frisén L, Schalling M, Osby U, Lavebratt C, Nikamo P.

PLoS One. 2010 Sep 9;5(9):e12632. doi: 10.1371/journal.pone.0012632.

14.

Prescribing patterns for treatment of pediatric bipolar disorder in a specialty clinic.

Potter MP, Liu HY, Monuteaux MC, Henderson CS, Wozniak J, Wilens TE, Biederman J.

J Child Adolesc Psychopharmacol. 2009 Oct;19(5):529-38. doi: 10.1089/cap.2008.0142.

15.
16.

Easing the burden of bipolar disorder: from urgent situations to remission.

[No authors listed]

Prim Care Companion J Clin Psychiatry. 2008;10(5):391-402. No abstract available.

17.

What to do if an initial antidepressant fails?

McIntyre RS, Müller A, Mancini DA, Silver ES.

Can Fam Physician. 2003 Apr;49:449-57. Review.

Items per page

Supplemental Content

Write to the Help Desk